Skip to main content
. 2012 Oct 5;2(1):418–432. doi: 10.1159/000338228

Table 3.

Drug regimens among patients on AChEIs and memantine

Number of patients (%) Median of daily dose, mg Mode of daily dose, mg Range of daily dose, mg
Donepezil 220 (25.7) 5.0 5.0 5.0–10.0
Rivastigmine (oral) 31 (3.6) 6.0 6.0 1.5–12.0
Rivastigmine (transdermal) 394 (46.1) 4.6 4.6 4.6–9.5
Galantamine 33 (3.9) 8.0 8.0 8.0–24.0
Memantine 177 (20.7) 20.0 20.0 5.0–20.0